Notable Labs
Notable Labs, Inc. is a clinical-stage company based in Foster City, California, focused on developing personalized testing services for cancer patients, particularly those with brain cancer. The company operates a platform that conducts drug combination experiments on tumors, providing actionable reports to doctors. These reports prioritize combinations of FDA-approved treatments that can be immediately prescribed, avoiding the need for lengthy clinical trials. Notable Labs utilizes its proprietary Predictive Precision Medicines Platform to bio-simulate cancer treatments, predicting patient responses to specific therapies. This approach aims to streamline the identification of patients likely to benefit from targeted treatments, thereby enhancing therapeutic development for cancer care.
MDS Foundation is an international organization dedicated to the prevention, treatment, and research of myelodysplastic syndromes.
VBL Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for cancer and immune-inflammatory diseases. The company’s clinical pipeline features two proprietary platform technologies that utilize the body’s natural biological and genetic mechanisms. Their lead product candidate, VB-111, is a gene-based biologic aimed at treating solid tumors, particularly recurrent glioblastoma, an aggressive brain cancer. In addition to its oncology efforts, VBL is also working on therapies for anti-inflammatory conditions through its Lecinoxoid platform technology. The company is dedicated to advancing first-in-class treatments that address significant unmet medical needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.